Blood News and Research

RSS

Hospitals may be unfairly punished for high readmission rates

When hospital patients have to be readmitted soon after discharge, hospitals look bad. A high readmission rate also can result in reduced Medicare reimbursements. But a study of spine surgery patients has found that the standard method used to calculate readmission rates is a misleading indicator of hospital quality.

16 Feb 2013

Research roundup: Conflict of interest in Medicaid drug purchasing; Examining Medigap policies; Electronic medical records and hospital quality

The authors of this study assert that the decisions about which drugs are selected for state Medicaid reimbursement programs "should be based on available evidence and free of conflicts of interests (COIs)."

15 Feb 2013

Frequent dialysis: it’s complicated

Patients who undergo hemodialysis on a frequent basis are at an increased risk for vascular access complications, requiring more vascular repair procedures to enable continued access to the blood, report Canadian researchers.

15 Feb 2013

VNI cures both acute and chronic forms of Chagas disease

Chagas disease, a deadly tropical infection caused by the protozoan parasite Trypanosoma cruzi and transmitted by biting insects called "kissing bugs," has begun to spread around the world, including the U.S. Yet current treatment is toxic and limited to the acute stage.

15 Feb 2013

New insights into how cells stick to each other and to other bodily structures

Research carried out by scientists at the Georgia Institute of Technology and The University of Manchester has revealed new insights into how cells stick to each other and to other bodily structures, an essential function in the formation of tissue structures and organs. It's thought that abnormalities in their ability to do so play an important role in a broad range of disorders, including cardiovascular disease and cancer.

15 Feb 2013

U.S. Marshals seize tainted dietary supplements from Globe All Wellness

U.S. Marshals, acting on behalf of the U.S. Food and Drug Administration, today seized tainted dietary supplements from Globe All Wellness, LLC (Globe All), in Hollywood, Fla. The products may be unsafe because they contain an undisclosed active pharmaceutical ingredient.

15 Feb 2013

Weekend reading: What your doctor should tell you, new stages of grief

Dr. Jim Dougher climbs into his white SUV, plugs the address of his next patient into the GPS, and he's off. The SUV is well stocked: He has a large Tupperware bin in the back full of bandages and wound cleaning supplies; he has a variation on the old-time doctor's bag with a stethoscope and blood-pressure cuff; and he has a dedicated cellular wifi hotspot and a laptop that can communicate with HealthCare Partner's electronic medical record.

15 Feb 2013

New progestogen-only treatment effective in stopping acute abnormal uterine bleeding

New research from the Los Angeles Biomedical Research Institute (LA BioMed) found a progestogen-only treatment halted bleeding in women suffering from extremely heavy periods, according to the study published online by the American Journal of Obstetrics and Gynecology.

15 Feb 2013

Researchers identify new molecular pathway involved in alveoli growth

In a study of mice, researchers at Johns Hopkins have identified a new molecular pathway involved in the growth of tiny air sacs called alveoli that are crucial for breathing. The scientists say their experiments may lead to the first successful treatments to regrow the air sacs in people who suffer from diseases such as emphysema in which the air sacs have been destroyed by years of smoking.

15 Feb 2013

Pairing Avastin with dasatinib can stop lethal spread of glioblastoma multiforme

The drug bevacizumab, also known by the trade name Avastin, shrinks tumors briefly in patients with an aggressive brain cancer known as glioblastoma multiforme, but then they often grow again and spread throughout the brain for reasons no one previously has understood. Now, Mayo Clinic researchers have found out why this happens.

15 Feb 2013

Study reveals how calcium signal repairs damaged tissue

For the first time scientists studying the cellular processes underlying the body's response to healing have revealed how a flash of calcium is the very first step in repairing damaged tissue. The findings, published in Current Biology, could lead to new therapies that speed up the healing process following injury or surgery.

15 Feb 2013

University of York develops new medical tool that could help surgeons during complex procedures

Scientists at the University of York have developed a new medical tool which could help surgeons carrying out complex procedures in the operating theatre.

15 Feb 2013

Effective approaches to prevent and control obesity among Latino children

Guided grocery store trips, menu labeling at restaurants, community gardens, and video-game-based exercise programs are among several promising, culturally appropriate ways to prevent obesity among Latino children, according to a new collection of studies from Salud America! The Robert Wood Johnson Foundation Research Network to Prevent Obesity Among Latino Children published in a supplement to the March issue of the American Journal of Preventive Medicine.

15 Feb 2013

FDA committee recommends approval of Guerbet’s Dotarem NDA for adults and children

Guerbet, the contrast agent specialist for medical imaging, today announced that the Medical Imaging Drugs Advisory Committee to US Food and Drug Administration (FDA) has voted unanimously by votes of 17 to 0 to recommend that FDA approve the New Drug Application (NDA) for Dotarem (gadoterate meglumine) for adults, and for pediatric use for children two years of age and older.

15 Feb 2013

Marshfield Clinic’s Heart Health Mobile app wins HSS competition

Marshfield Clinic Research Foundation, a division of Marshfield Clinic, announced today that its first completed mobile app has won a national competition that challenged competitors to develop a program that will help improve heart health in the U.S.

15 Feb 2013

ReCor Medical initiates PARADISE system post-market study in high blood pressure

ReCor Medical announced today that it has commenced a 50-patient, post-market study across multiple sites in Europe with its CE-marked next-generation PARADISE system, a minimally invasive 6Fr Over-The-Wire (OTW) ultrasound device for treating resistant high blood pressure.

15 Feb 2013

Blood News and Research

Hospitals may be unfairly punished for high readmission rates

Research roundup: Conflict of interest in Medicaid drug purchasing; Examining Medigap policies; Electronic medical records and hospital quality

Frequent dialysis: it’s complicated

VNI cures both acute and chronic forms of Chagas disease

New insights into how cells stick to each other and to other bodily structures

U.S. Marshals seize tainted dietary supplements from Globe All Wellness

Weekend reading: What your doctor should tell you, new stages of grief

New progestogen-only treatment effective in stopping acute abnormal uterine bleeding

Researchers identify new molecular pathway involved in alveoli growth

Pairing Avastin with dasatinib can stop lethal spread of glioblastoma multiforme

Study reveals how calcium signal repairs damaged tissue

University of York develops new medical tool that could help surgeons during complex procedures

Effective approaches to prevent and control obesity among Latino children

FDA committee recommends approval of Guerbet’s Dotarem NDA for adults and children

Marshfield Clinic’s Heart Health Mobile app wins HSS competition

ReCor Medical initiates PARADISE system post-market study in high blood pressure

ADAMTS7 enzyme plays a crucial role in coronary heart disease

LLS, The Myeloproliferative Neoplasm Research Foundation issue MF Challenge Grant

Gamida Cell announces results from NiCord Phase I/II study on hematological malignancies

Blocking C5a protein prevents low birth weight in babies born to pregnant women with malaria

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News